試す 金 - 無料
“Covid-19 Highlighted The Limitations Of Our Current Healthcare Infrastructure”
BioSpectrum Asia
|August 2020
COVID-19 has exposed the inadequacies in the healthcare industry, which is now evolving through vigorous transformation. The Asia Pacific (APAC) region is embracing digital transformation in the healthcare ecosystem. According to a 2020 report by Bain & Company, the APAC region is set to represent more than 40 per cent of growth in global healthcare spending over the next decade, expanding at a rate almost double than that of the rest of the world. This also means that APAC stakeholders have an unprecedented opportunity to transform the region’s healthcare landscape through collaboration and networking tools. Dirk Dumortier, Head of Business Development, Smart City and Healthcare (Asia Pacific) at Alcatel-Lucent Enterprise, Singapore, shared his views with BioSpectrum Asia about the new framework for healthcare delivery. Edited excerpts;

Dirk Dumortier, Head of Business Development SmartCity and Healthcare (APAC region), Alcatel-Lucent Enterprise, Singapore
What does healthcare continuity mean in the times of COVID-19?
There are two aspects to consider in healthcare continuity – operational needs and technical needs.
Operational needs involve ensuring that health facilities like clinics and hospitals remain operating during a pandemic while protecting both patients and healthcare workers. There are multiple ways to go about this. For instance, the building of temporary wards or rearranging normal wards into Intensive Care Units (ICUs) to cater to the surge in demand. Minimizing physical contact between patients and healthcare workers using collaboration tools that allow for shift handovers to be done remotely. Or the use of collaboration tools to enable administrative staff to work from home and general practitioners to reach out to their patients remotely.
Technical needs refer to the technologies that allow healthcare facilities to resolve operational requirements within a short time frame. Hospitals and clinics need to tap on technology that allows for:
Ruggedised network infrastructure to create secure wired and wireless connectivity for both hospital and patient use.
Work from home software and hardware – extending the hospital and care network and communications to home, allowing staff to work remotely without affecting operations.
Over-the-top (OTT) cloud collaboration licenses for free to all healthcare workers. This managed service does not require any onsite installations and can be rolled out quickly, enabling collaboration between hospitals and clinics, and even teleconsultations.
このストーリーは、BioSpectrum Asia の August 2020 版からのものです。
Magzter GOLD を購読すると、厳選された何千ものプレミアム記事や、9,500 以上の雑誌や新聞にアクセスできます。
すでに購読者ですか? サインイン
BioSpectrum Asia からのその他のストーリー

BioSpectrum Asia
Collaborative R&D: Partnerships shaping the future of biopharma
Biotechs and pharma companies face rising costs of drug development, depleting R&D pipelines and diminishing returns on investment. By joining forces and exploring collaborative R&D partnerships it is possible to overcome these challenges. In addition to sharing risks, they share the potential rewards when their assets move further into clinical development or come to the market.
2 mins
BioSpectrum Asia Sep 2025

BioSpectrum Asia
Quantum Computing: Future of diagnostics is being coded today
A silent revolution is being built at the intersection of biology and quantum physics. After decades of pushing the boundaries of diagnostics with advanced imaging and AI, we are now approaching a hard computational wall. For complex conditions like Alzheimer's, Parkinson's, and many cancers, the interacting variables of genomics, proteomics, and real-world patient data are simply too vast for classical computers to master. This limitation caps the ability to move from merely spotting correlations to uncovering true causation. Unlike traditional AI, quantum computing can simulate underlying physical systems to derive precise solutions. The transition from correlational analysis to causal simulation will enable a more valuable and advanced frontier in diagnostics.
4 mins
BioSpectrum Asia Sep 2025
BioSpectrum Asia
First Pacific woman to serve as public health director in NZ
The Ministry of Health in New Zealand (NZ) has appointed Dr Corina Grey as the new Director of Public Health this year, a landmark appointment for Pacific leadership.
1 min
BioSpectrum Asia Sep 2025
BioSpectrum Asia
Bio-Rad appoints Rajat Mehta as Executive Vice President of Global Commercial Operations
Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostics products, has announced the appointment of Rajat Mehta as its new Executive Vice President, Global Commercial Operations, effective August 4, 2025.
1 min
BioSpectrum Asia Sep 2025

BioSpectrum Asia
Hugel launches botulinum toxin Letybo in Malaysia
South Korea-based Hugel Inc., a leading global medical aesthetics company, has officially launched its botulinum toxin product Letybo in Malaysia - an emerging market for medical aesthetics in Southeast Asia.
1 min
BioSpectrum Asia Sep 2025

BioSpectrum Asia
Australia designs smart wound monitor to improve chronic infection care
Researchers from Australia's RMIT University have developed a wearable wound monitoring device with integrated sensors that could reduce infection risks by minimising the need for frequent physical contact.
1 min
BioSpectrum Asia Sep 2025
BioSpectrum Asia
Revvity unveils innovative reagent technology to accelerate therapeutics development
US-based Revvity, Inc. has announced the launch of pHSense reagents, a powerful technology designed to advance internalisation studies in drug discovery.
1 min
BioSpectrum Asia Sep 2025

BioSpectrum Asia
Sanofi acquires next-gen vaccine biotech Vicebio for $1.6 B
Vicebio, a biopharmaceutical company with operations in Australia, UK and Belgium, has entered an exclusive, definitive agreement to be acquired by Sanofi.
1 min
BioSpectrum Asia Sep 2025
BioSpectrum Asia
HOSMAC signs MoU with Gulf Medical University to strengthen healthcare education
HOSMAC, Asia's leading hospital planning, design, and management consultancy, has signed a Memorandum of Understanding (MoU) with Gulf Medical University (GMU), Ajman, UAE, to serve as an industry partner.
1 min
BioSpectrum Asia Sep 2025
BioSpectrum Asia
Jessica Cowden takes charge as Deputy Director General of CARE unit at IVI
Dr Jessica Cowden has been appointed Deputy Director General of the Clinical, Assessment, Regulatory, Evaluation (CARE) unit at South Korea-headquartered International Vaccine Institute (IVI). She will continue to be based at IVI's Europe Regional Office in Stockholm, Sweden.
1 min
BioSpectrum Asia Sep 2025
Translate
Change font size